Crescita Therapeutics (CTX) Competitors C$0.58 -0.01 (-1.69%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlines CTX vs. VIR, ZOM, IN, META, CWEB, LABS, DB, NRTH, MRV, and WLLWShould you be buying Crescita Therapeutics stock or one of its competitors? The main competitors of Crescita Therapeutics include Viridium Pacific Group (VIR), Zomedica Pharmaceuticals Corp. (ZOM.V) (ZOM), InMed Pharmaceuticals (IN), Meta Growth (META), Charlotte's Web (CWEB), MediPharm Labs (LABS), Decibel Cannabis (DB), 48North Cannabis (NRTH), Nuvo Pharmaceuticals (MRV), and Willow Biosciences (WLLW). These companies are all part of the "drug manufacturers - specialty & generic" industry. Crescita Therapeutics vs. Viridium Pacific Group Zomedica Pharmaceuticals Corp. (ZOM.V) InMed Pharmaceuticals Meta Growth Charlotte's Web MediPharm Labs Decibel Cannabis 48North Cannabis Nuvo Pharmaceuticals Willow Biosciences Viridium Pacific Group (CVE:VIR) and Crescita Therapeutics (TSE:CTX) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, risk, dividends, earnings, analyst recommendations, institutional ownership, community ranking and media sentiment. Does the media favor VIR or CTX? In the previous week, Viridium Pacific Group and Viridium Pacific Group both had 1 articles in the media. Viridium Pacific Group's average media sentiment score of 0.00 equaled Crescita Therapeutics'average media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Viridium Pacific Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Crescita Therapeutics 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has stronger valuation and earnings, VIR or CTX? Crescita Therapeutics has higher revenue and earnings than Viridium Pacific Group. Crescita Therapeutics is trading at a lower price-to-earnings ratio than Viridium Pacific Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioViridium Pacific GroupC$1.09M34.46-C$12.64M-C$0.13-2.97Crescita TherapeuticsC$16.84M0.67-C$2.98M-C$0.15-3.87 Do analysts recommend VIR or CTX? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Viridium Pacific Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/ACrescita Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Is VIR or CTX more profitable? Viridium Pacific Group has a net margin of 0.00% compared to Crescita Therapeutics' net margin of -17.72%. Viridium Pacific Group's return on equity of 0.00% beat Crescita Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Viridium Pacific GroupN/A N/A N/A Crescita Therapeutics -17.72%-15.79%-8.26% Does the MarketBeat Community believe in VIR or CTX? Crescita Therapeutics received 20 more outperform votes than Viridium Pacific Group when rated by MarketBeat users. However, 83.33% of users gave Viridium Pacific Group an outperform vote while only 67.42% of users gave Crescita Therapeutics an outperform vote. CompanyUnderperformOutperformViridium Pacific GroupOutperform Votes4083.33% Underperform Votes816.67%Crescita TherapeuticsOutperform Votes6067.42% Underperform Votes2932.58% SummaryViridium Pacific Group beats Crescita Therapeutics on 7 of the 10 factors compared between the two stocks. Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Get Crescita Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CTX vs. The Competition Export to ExcelMetricCrescita TherapeuticsDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapC$11.24MC$1.22BC$5.40BC$5.94BDividend YieldN/A3.13%5.15%5.37%P/E Ratio-3.87110.73112.5525.87Price / Sales0.673,426.271,478.821,515.70Price / Cash1.2010.1939.8381.06Price / Book0.653.174.643.11Net Income-C$2.98MC$155.16MC$119.13MC$292.76M7 Day Performance-3.33%-0.07%0.78%-1.65%1 Month Performance-3.33%-0.75%5.65%2.32%1 Year Performance-4.92%100.86%36.90%45.73% Crescita Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CTXCrescita TherapeuticsN/AC$0.58-1.7%N/A-3.3%C$11.24MC$16.84M-3.8762News CoverageVIRViridium Pacific GroupN/AC$0.38+5.6%N/A+0.0%C$37.52MC$1.09M-2.97580Gap UpZOMZomedica Pharmaceuticals Corp. (ZOM.V)N/AC$0.29-6.6%N/A+0.0%C$36.73MN/A-2.6150Gap DownINInMed PharmaceuticalsN/AN/AN/AN/AC$33.73MC$574,677.00-2.7712METAMeta GrowthN/AC$0.14flatN/A+0.0%C$33.14MC$60.96M-0.6686,500News CoverageGap DownCWEBCharlotte's WebN/AC$0.21flatN/A-41.2%C$33.08MC$54.55M-0.53164Gap DownLABSMediPharm LabsN/AC$0.08flatN/A+0.0%C$30.83MC$37.76M-1.88130Gap UpHigh Trading VolumeDBDecibel Cannabis1.5546 of 5 starsC$0.06+9.1%C$0.28+372.2%-48.1%C$24.54MC$105.60M-6.0083,000Analyst RevisionNews CoverageGap DownHigh Trading VolumeNRTH48North CannabisN/AC$0.07-6.7%N/A+0.0%C$15.76MC$18.90M-0.3047MRVNuvo PharmaceuticalsN/AN/AN/AN/AC$15.38MC$72.42M-19.29N/AWLLWWillow BiosciencesN/AC$0.09flatN/A+12.5%C$12.26MC$1.84M-1.4219Gap Up Related Companies and Tools Related Companies VIR Alternatives ZOM Alternatives IN Alternatives META Alternatives CWEB Alternatives LABS Alternatives DB Alternatives NRTH Alternatives MRV Alternatives WLLW Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (TSE:CTX) was last updated on 11/2/2024 by MarketBeat.com Staff From Our PartnersEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Crescita Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Crescita Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
